protein
nucleic
acid
easili
administ
syring
needl
gener
biocompat
provid
high
bioavail
capabl
sustain
releas
long
period
time
sever
commerci
product
base
polym
microspher
includ
lupron
depot
r
nutropin
depot
r
disadvantag
microspher
includ
difficulti
largescal
manufactur
inactiv
drug
fabric
poor
control
drug
releas
rate
exampl
nutropin
depot
compris
genentech
recombin
human
growth
hormon
rhgh
encapsul
within
poli
llactidecoglycolid
plg
microspher
use
alkerm
proprietari
proleas
r
encapsul
technolog
recent
pull
market
manufactur
product
cost
high
chapter
factor
control
drug
releas
rate
review
follow
sever
exampl
controlledreleas
microspher
applic
importantli
method
microparticl
fabric
describ
particular
chapter
focu
precis
particl
fabric
ppf
method
report
recent
ppf
provid
unpreced
control
particl
size
size
distribut
morpholog
may
translat
enhanc
control
drug
releas
rate
improv
understand
mechan
control
releas
microspher
fabric
method
govern
factor
encapsul
releas
therapeut
addit
complic
array
factor
includ
type
polym
polym
molecular
weight
copolym
composit
natur
excipi
ad
microspher
formul
eg
stabil
therapeut
microspher
size
strong
impact
deliveri
rate
first
type
polym
use
microspher
fabric
way
polym
degrad
obvious
affect
drug
releas
rate
depend
rate
hydrolysi
function
group
polym
broadli
categor
two
type
surfaceerod
bulkerod
bulkerod
polym
plg
readili
allow
permeat
water
polym
matrix
degrad
throughout
microspher
matrix
contrast
surfaceerod
polym
polyanhydrid
compos
rel
hydrophob
monom
link
labil
bond
way
abl
resist
penetr
water
polym
bulk
degrad
quickli
oligom
monom
polymerwat
interfac
via
hydrolysi
bulkerod
polym
microspher
often
character
burst
druga
much
total
drug
load
releas
first
hour
incub
follow
slow
diffusioncontrol
releas
sometim
third
phase
remain
drug
releas
quickli
result
sever
degrad
polym
matrix
microspher
compos
surfaceerod
polym
drug
releas
primarili
surfac
polym
break
around
eros
polym
usual
proce
constant
veloc
drug
interest
homogen
dispers
throughout
microspher
largest
rate
releas
occur
begin
time
proce
surfac
area
sphere
releas
rate
decreas
asymptot
polym
molecular
weight
affect
polym
degrad
drug
releas
rate
one
might
expect
increas
molecular
weight
decreas
diffus
therefor
drug
releas
rate
addit
major
mechan
releas
mani
drug
diffus
waterfil
pore
form
polym
degrad
gener
solubl
monom
oligom
diffus
particl
small
product
form
quickli
upon
degrad
lower
molecular
weight
polym
decreas
releas
rate
increas
polym
molecular
weight
appear
hold
small
molecul
peptid
protein
howev
molecular
weight
typic
littl
effect
releas
rate
surfaceerod
polyanhydrid
microspher
comonom
ratio
mani
copolym
also
affect
releas
rate
often
increas
content
rapidli
degrad
monom
increas
releas
rate
similarli
drug
releas
control
polym
eros
releas
rate
typic
increas
higher
concentr
smaller
andor
solubl
monom
howev
effect
copolym
composit
complic
differ
polym
phase
behavior
thermodynam
encapsul
drug
varieti
excipi
may
ad
microspher
formul
stabil
drug
fabric
andor
releas
may
impact
drug
releas
sever
differ
mechan
exampl
improv
encapsul
bovin
serum
albumin
bsa
microspher
poli
pcl
plg
yang
et
al
includ
poli
vinyl
alcohol
pva
bsa
solut
stabil
primari
emuls
result
uniform
bsa
distribut
microspher
increas
concentr
pva
decreas
initi
burst
protein
overal
releas
rate
jain
et
al
encapsul
myoglobin
plg
microspher
presenc
stabil
mannitol
report
mannitol
increas
releas
rate
final
amount
drug
releas
increas
initi
poros
plg
matrix
lead
faster
format
pore
network
within
sphere
due
polym
eros
clearli
microspher
size
strongli
affect
rate
drug
releas
size
decreas
surfac
areatovolum
ratio
particl
increas
thu
given
rate
drug
diffus
microspher
rate
flux
drug
microspher
per
mass
formul
increas
decreas
particl
size
addit
water
penetr
smaller
particl
may
quicker
due
shorter
distanc
surfac
center
particl
also
decreas
surfac
area
particl
size
may
lead
decreas
rate
eros
poorli
waterperm
polym
like
polyanhydrid
surfac
areatovolum
ratio
increas
decreas
particl
size
drug
releas
rate
per
mass
polym
faster
smaller
polyanhydrid
microspher
controlledreleas
microspher
develop
number
interest
import
applic
especi
deliveri
larg
fragil
drug
like
protein
nucleic
acid
sever
recent
exampl
describ
vaccin
highli
success
control
even
erad
mani
import
type
infecti
diseas
new
improv
vaccin
heavili
investig
aid
hepat
b
anthrax
sar
frequent
problem
need
repeat
administrationsusu
injectionsto
ensur
longlast
immun
exampl
current
anthrax
vaccin
requir
seri
booster
week
month
follow
first
inocul
recombivax
hb
r
vaccin
hepat
brequir
healthcar
worker
usi
administ
three
inject
month
need
multipl
inject
pose
seriou
problem
patient
develop
countri
limit
access
medic
care
awar
lack
transient
popul
one
promis
altern
singleshot
vaccin
drug
deliveri
devic
provid
necessari
booster
specifi
time
administr
abil
precis
control
time
cours
vaccin
deliveri
may
lead
effect
vaccin
current
antigen
may
allow
util
antigen
previous
ineffect
singleshot
vaccin
deliveri
system
provid
antigen
adjuv
prescrib
schedul
maintain
bioactiv
antigen
fabric
deliveri
devic
often
prolong
resid
time
devic
bodi
recent
year
much
work
focus
develop
microspherebas
singleadministr
vaccin
deliveri
vehicl
use
varieti
materi
includ
hydroxypropyl
celluloseplg
poli
pla
chitosan
collagen
though
major
fabric
plg
mainten
antigen
bioactiv
problemat
due
contact
protein
organ
solvent
hydrophob
polym
use
strong
physic
forc
produc
microspher
enhanc
vaccin
stabil
research
focus
sever
approach
includ
use
adjuv
protect
protein
antigen
choos
differ
microspher
materi
major
advantag
microspher
vaccin
passiv
target
antigenpres
cell
apc
macrophag
dendrit
cell
abil
apc
phagocytos
particul
depend
particl
size
particular
diamet
microspher
optim
taken
apc
number
tissu
shown
enhanc
antigenspecif
thelper
lymphocyt
th
respons
thu
lead
enhanc
antigenspecif
antibodi
respons
elicit
cytotox
lymphocyt
ctl
respons
nixon
et
al
tcell
activ
respons
antigenencapsul
microspher
shown
fold
better
antigen
alon
major
problem
protein
encapsul
polym
particl
loss
protein
bioactiv
damag
protein
occur
fabric
particlesvia
shear
stress
physic
forc
contact
organ
solvent
loss
water
eg
upon
lyophil
well
incub
releas
warm
moist
vivo
environ
two
type
damag
occur
often
coval
noncoval
intermolecular
aggreg
ii
denatur
sever
studi
investig
mechan
damag
protein
stabil
enhanc
addit
excipi
prevent
aggreg
stabil
fold
protein
structur
judici
choic
polym
employ
fabric
devic
although
number
type
stabil
excipi
studi
poli
ethylen
glycol
peg
sugar
common
exampl
perezrodriguez
et
al
recent
report
codissolv
peg
w
maltos
primari
emuls
greatli
reduc
protein
aggreg
inactiv
similar
studi
castellano
et
al
use
peg
enhanc
stabil
encapsul
plg
microspher
form
solidinoilinwat
sow
emuls
process
report
normal
encapsul
procedur
protein
lyophil
buffer
trehalos
solut
caus
protein
aggreg
loss
activ
colyophil
protein
peg
prior
encapsul
reduc
activ
loss
protein
still
aggreg
encapsul
use
peg
emulsifi
secondari
ow
emuls
result
microspher
free
protein
aggreg
enzym
complet
maintain
activ
upon
extract
particl
similar
stabil
horseradish
peroxidas
hrp
bsa
achiev
techniqu
suggest
may
gener
approach
protein
stabil
final
jiang
schwendeman
report
upon
blend
wt
peg
pla
microspher
encapsul
bsa
protein
aggreg
avoid
vitro
protein
releas
sustain
day
type
excipi
also
effect
stabil
protein
lysozym
inactiv
precipit
aggreg
larg
prevent
upon
format
primari
emuls
addit
mm
potassium
phosphat
activ
protein
larg
unaffect
acid
microclim
result
accumul
polym
degrad
product
major
factor
caus
protein
instabl
degrad
microspher
schwendeman
cowork
show
addit
buffer
salt
stabil
encapsul
protein
zhu
et
al
demonstr
coencapsul
magnesium
hydroxid
mg
oh
antacid
increas
microclim
ph
plg
millicylind
microspher
contain
bsa
devic
mg
oh
show
minim
bsa
aggreg
exhibit
smaller
burst
effect
nonaggreg
bsa
compar
cylind
without
antacid
type
polym
use
microspher
fabric
degrad
rate
acid
degrad
product
hydrophob
etc
also
impact
stabil
encapsul
protein
although
plg
common
polym
use
polym
microspher
peg
combin
polyest
form
poli
llactid
copoli
ethylen
glycol
pela
diblock
copolym
plapegpla
triblock
copolym
plgpegplg
triblock
thought
hydrophil
peg
may
improv
affin
protein
matrix
polym
lead
better
entrap
effici
gene
therapi
hold
tremend
potenti
treat
genet
diseas
acquir
diseas
includ
cancer
vaccin
major
barrier
develop
genebas
pharmaceut
safe
effici
dna
deliveri
much
research
focus
develop
gene
deliveri
vector
includ
virus
liposom
polym
howev
parenter
administr
nake
plasmid
dna
pdna
lead
gene
express
control
releas
pdna
polymer
matric
microparticl
nanoparticl
report
recent
particular
encapsul
control
releas
pdna
biodegrad
microspher
may
provid
number
advantag
includ
protect
nucleas
degrad
access
altern
rout
administr
eg
nasal
pulmonari
oral
mucos
passiv
target
profession
antigenpres
cell
prolong
gene
express
problem
current
face
design
new
dnaload
microparticl
formul
includ
loss
bioactiv
poor
encapsul
effici
low
load
due
difficulti
encapsul
larg
hydrophil
macromolecul
hydrophob
polym
matrix
plasmid
dna
particularli
suscept
damag
physic
forc
especi
shear
forc
employ
microspher
fabric
process
addit
loss
structur
integr
result
exposur
acid
environ
ando
et
al
devis
novel
emulsionsolv
extractionevapor
method
dnaload
microspher
encapsul
prevent
shearinduc
damag
plasmid
method
primari
wo
emuls
compris
aqueou
dna
solut
polymersolv
continu
phase
form
sonic
quickli
frozen
liquid
nitrogen
emuls
allow
warm
slowli
reach
temperatur
organ
phase
melt
aqueou
phase
remain
frozen
primari
emulsionactu
suspens
ice
particlesi
homogen
water
form
microspher
dna
entrap
frozen
droplet
plasmid
experi
shear
forc
employ
homogen
microspher
prepar
optim
procedur
dna
retain
nativ
conform
compar
use
convent
process
microspher
drug
deliveri
system
fabric
varieti
techniqu
includ
combin
phase
separ
precipit
young
emulsionsolv
evapor
andor
spray
method
variat
fabric
paramet
gener
allow
control
particl
size
size
distribut
drug
may
incorpor
particl
sever
differ
way
depend
properti
drug
hydrophob
therapeut
may
codissolv
polym
solvent
methylen
chlorid
ethyl
acet
hydrophil
therapeut
includ
protein
may
suspend
organ
phase
fine
ground
dri
powder
altern
aqueou
solut
hydrophil
therapeut
may
mix
organ
polym
solut
form
waterinoil
emuls
emulsionsolv
extractionevapor
method
commonli
use
especi
lab
scale
process
solut
contain
polym
possibl
drug
encapsul
emulsifi
nonsolv
phase
continu
phase
contain
stabil
emuls
prepar
varieti
physic
method
includ
homogen
sonic
compon
chosen
solvent
slightli
solubl
nonsolv
exampl
produc
microspher
plg
polyanhydrid
common
solvent
methylen
chlorid
ethyl
acet
use
conjunct
aqueou
continu
phase
contain
poli
vinyl
alcohol
pva
stabil
emulsif
solvent
extract
continu
phase
allow
evapor
time
nonsolv
may
penetr
polymerrich
droplet
due
loss
solvent
dispers
phase
enrich
polym
droplet
harden
becom
particl
microspher
may
filter
wash
lyophil
sever
disadvantag
emuls
solventextractionevapor
techniqu
limit
applic
method
inher
batch
oper
scale
process
difficult
largescal
product
costli
anoth
critic
problem
size
distribut
particl
gener
reproduc
nonuniform
standard
deviat
distribut
equal
averag
size
uncommon
sinc
size
sphere
directli
affect
drug
releas
rate
syring
import
size
distribut
rel
narrow
addit
describ
presenc
organ
solvent
aqueousorgan
interfac
may
advers
effect
encapsul
drug
decreas
even
elimin
bioactiv
organ
solvent
also
may
difficult
remov
complet
sinc
mani
commonli
use
organ
solvent
eg
methylen
chlorid
toxic
concentr
residu
solvent
microspher
must
tightli
regul
point
preced
section
import
limit
develop
biodegrad
polym
microspher
controlledreleas
drug
deliveri
applic
difficulti
specif
design
system
exhibit
precis
control
releas
rate
microparticl
size
primari
determin
drug
releas
worthwhil
develop
methodolog
control
releas
kinet
employ
monodispers
microspher
sever
report
fabric
uniform
biodegrad
polym
microspher
amsden
goosen
use
electrostat
form
evac
sphere
diamet
smaller
nozzl
spray
minimum
size
obtain
howev
conclud
possibl
obtain
small
microbead
narrow
size
distribut
amsden
later
report
product
uniform
microspher
extrud
polym
solut
nozzl
stabil
solut
flow
perpendicular
point
inject
plg
solut
droplet
exit
nozzl
drawn
pva
solut
period
fashion
rate
droplet
remov
nozzl
thereforeund
constant
polym
flow
rateth
size
microspher
determin
properti
stabil
solut
densiti
viscos
diamet
nozzl
interfaci
tension
polym
solut
needl
tip
amsden
report
plg
microspher
diamet
rang
howev
size
distribut
vari
wide
standard
deviat
typic
averag
size
minimum
standard
deviat
averag
microspher
furthermor
format
small
particl
may
possibl
techniqu
reduct
particl
size
would
appar
requir
smaller
nozzl
nozzl
size
decreas
shear
forc
orific
potenti
clog
increas
summari
sever
report
fabric
biodegrad
polym
microspher
control
uniform
size
howev
none
method
success
gener
particl
size
rang
appropri
drug
deliveri
maintain
narrow
size
distribut
addit
convent
method
appear
difficult
scaleup
commerci
applic
remedi
situat
develop
novel
microspher
fabric
technolog
combin
two
techniqu
gener
monodispers
microspher
precis
control
size
precis
particl
fabric
ppf
technolog
also
allow
fabric
predefin
particl
size
distribut
via
continu
variat
process
paramet
polyanhydrid
ethylcellulos
chitosan
hetastarch
gelatin
hydrogel
gener
ppf
apparatu
figur
design
pass
solut
contain
sphere
materi
drug
encapsul
small
nozzl
orific
millimet
diamet
form
smooth
cylindr
jet
nozzl
vibrat
piezoelectr
transduc
driven
wave
gener
frequenc
tune
match
flow
rate
desir
drop
size
mechan
excit
launch
acoust
wave
along
liquid
jet
gener
period
instabl
turn
break
stream
train
uniform
droplet
figur
apparatu
alon
minimum
particl
size
achiev
approxim
twice
nozzl
open
approach
repres
improv
convent
ultrason
nozzl
acoust
wave
intens
lower
tightli
control
match
frequenc
solut
flow
rate
control
sphere
size
fact
form
droplet
much
smaller
nozzl
open
employ
annular
flow
nonsolv
phase
around
polym
jet
figur
annular
stream
pump
linear
veloc
greater
polym
stream
thu
friction
contact
two
stream
gener
addit
downward
forc
effect
pull
polym
solut
away
tip
nozzl
polym
stream
acceler
forc
therefor
thin
degre
depend
differ
linear
veloc
two
stream
carrier
stream
allow
product
microspher
much
smaller
orific
size
thu
addit
carrier
stream
accommod
highviscos
materi
reduc
risk
clog
allow
use
larg
nozzl
order
predict
process
paramet
flow
rate
acoust
frequenc
requir
gener
particl
desir
size
size
distribut
necessari
understand
theori
droplet
format
appli
ppf
system
technolog
lord
rayleigh
first
investig
instabl
cylindr
inviscid
jet
subject
disturb
found
unstabl
wavelength
max
disturb
impos
jet
surfac
give
rise
maximum
growth
rate
consequ
result
breakup
jet
uniform
droplet
figur
r
j
radiu
undisturb
jet
approxim
equal
typic
slightli
larger
diamet
nozzl
orific
practic
rang
acoust
wavelength
give
rise
breakup
liquid
jet
uniform
droplet
experiment
determin
j
j
upper
lower
wavelength
limit
may
vari
somewhat
depend
nois
level
system
amplitud
acoust
wave
microspher
gener
develop
us
allow
control
acoust
wave
frequenc
amplitud
wavelength
produc
set
frequenc
f
given
v
j
linear
veloc
liquid
jet
know
volum
result
sphere
equal
volum
cylindr
element
jet
length
defin
acoust
wavelength
find
drop
radiu
r
predict
optimum
wavelength
r
max
r
j
thu
impos
uniform
highamplitud
oscil
nozzl
domin
random
natur
instabl
control
breakup
stream
droplet
predict
orific
size
j
solut
flow
rate
v
j
acoust
frequenc
f
need
gener
desir
sphere
size
size
distribut
uniform
microspher
control
size
solid
hollow
previous
fabric
varieti
nonpolymer
materi
use
acoust
excit
recent
demonstr
ppf
technolog
fabric
monodispers
microspher
variou
polym
plg
polyanhydrid
ec
chitosan
gelatin
hydrogel
hetastarch
averag
diamet
figur
micrograph
clearli
demonstr
ppf
technolog
produc
uniform
polymer
microspher
precis
control
size
b
use
produc
particl
much
smaller
nozzl
open
c
insensit
choic
materi
also
demonstr
encapsul
vitro
releas
model
drug
compound
rhodamin
b
piroxicam
nifedipin
felodipin
releas
kinet
compound
depend
strongli
microspher
size
expect
detail
vitro
releas
profil
mechan
discuss
abil
form
microcapsul
exhibit
predefin
diamet
shell
thick
may
offer
sever
addit
advantag
drug
deliveri
higher
drug
load
may
realiz
util
core
materi
offer
increas
drug
solubl
addit
fragil
therapeut
protein
dna
may
stabil
gener
favor
environ
core
advanc
drug
releas
schedul
delay
pulsatil
releas
remov
drug
burst
may
possibl
select
vari
shell
materi
especi
thick
exampl
surfaceerod
polym
eg
polyanhydrid
shell
may
expect
protect
polyest
core
encapsul
drug
prolong
time
durat
govern
shell
thick
howev
effici
fabric
particl
previous
report
knowledg
final
drug
could
releas
tandem
select
load
core
shell
phase
therebi
potenti
enhanc
drug
efficaci
coreshel
microparticl
significantli
difficult
manufactur
solid
microspher
varieti
techniqu
fabric
microcapsul
vari
size
report
exampl
variat
common
doubleemuls
approach
also
use
prepar
microcapsul
allow
discontinu
phase
primari
emuls
coalesc
form
core
particl
particl
shown
interest
pulsatil
releas
profil
may
advantag
vaccin
deliveri
import
limit
approach
howev
core
shell
materi
must
immisc
microcapsul
architectur
difficult
control
core
size
shell
thick
depend
strongli
properti
primari
emuls
time
emuls
allow
coalesc
also
possibl
gener
microcapsul
solid
core
coat
preform
microparticl
second
materi
exampl
et
al
develop
ingeni
method
coat
microspher
second
layer
polym
resuspend
preform
microspher
concentr
solut
second
polym
follow
reemulsifi
suspens
aqueou
continu
phase
form
microencapsul
microspher
presum
shell
thick
control
vari
polym
concentr
mass
ratio
two
materi
miscibl
one
anoth
howev
thinnest
shell
report
overal
particl
diamet
doublewal
particl
compris
polym
core
shell
form
control
phase
separ
two
sphereform
materi
one
first
studi
consist
ad
two
separ
polym
dropwis
aqueou
phase
control
precipit
rate
one
polym
ampl
time
spread
anoth
techniqu
util
phase
separ
plg
pll
certain
concentr
radiosensit
etanidazol
suspend
fine
filament
plg
phase
two
polym
emulsifi
form
milki
solut
rel
prolong
extract
solvent
larg
particl
two
polym
phasesepar
polym
still
remain
core
shell
phase
etanidazol
entrap
primarili
plg
core
due
higher
affin
plg
phase
recent
polyorthoest
poe
encapsul
plg
shell
studi
overal
polym
concentr
remain
constant
wt
polymervol
dcm
poe
plg
polym
ratio
adjust
produc
doublewal
microspher
poe
account
polym
weight
coreshel
particl
plg
shell
form
microspher
intermingl
polym
phase
form
ratio
simpl
scalabl
process
sever
factor
seem
influenc
format
complet
microcapsul
first
interfaci
tension
three
phase
polym
polym
aqueou
nonsolv
indic
polym
tend
spread
spread
coeffici
case
therefor
expect
function
polym
chemistri
solvent
type
polym
concentr
reli
thermodynam
driven
techniqu
form
microcapsul
may
necessit
extend
solvent
extract
time
allow
two
polym
phase
come
intim
contact
phase
separ
form
coreshel
arrang
polym
solut
precipit
extend
solvent
extract
time
may
achiev
review
work
creat
larg
particl
thu
larg
nascent
polym
droplet
lower
polym
concentr
lower
temperatur
nonsolv
bath
ad
solvent
extract
phase
thu
achiev
architectur
type
drug
encapsul
shell
thick
obtain
releas
kinet
achiev
may
limit
follow
previou
work
report
product
coreshel
particl
made
varieti
inorgan
materi
uniform
solid
microspher
fabric
methodolog
describ
preced
section
figur
extend
produc
uniform
doublewal
polymer
microspher
control
size
shell
thick
method
illustr
figur
employ
three
coaxial
nozzl
produc
smooth
coaxial
jet
control
size
compris
carrier
annular
shell
core
stream
acoust
excit
break
uniform
coreshel
droplet
nonsolv
carrier
stream
surround
coaxial
jet
acceler
make
thinner
breakup
orient
jet
materi
flow
rate
rate
solvent
extract
control
vari
shell
thick
microcapsul
fabric
differ
arrang
bulkerod
poli
llactidecoglycolid
plg
surfaceerod
poli
hexan
pcph
variat
fabric
paramet
allow
complet
encapsul
shell
phase
includ
effici
format
pcph
shell
encapsul
plg
core
util
technolog
microcapsul
shell
thick
vari
ten
micron
maintain
complet
wellcent
core
encapsul
microcapsul
near
overal
diamet
scan
electron
micrograph
microcapsul
origin
contain
oil
aqueou
core
shown
figur
pcph
shellplg
core
plg
corepcph
shell
microcapsul
shown
figur
micrograph
proof
modifi
ppf
technolog
effect
singlestep
carrier
stream
shell
solut
figur
schemat
descript
triplenozzl
ppf
methodolog
produc
uniform
coreshel
droplet
use
acoust
carrier
stream
scheme
method
produc
uniform
polymer
microcapsul
control
size
shell
thick
monodispers
precis
defin
particl
size
distribut
achiev
maintain
desir
polymer
shell
thick
comparison
convent
coreshel
particl
method
describ
precis
particl
fabric
ppf
technolog
spray
polym
solut
immedi
brought
intim
contact
distinct
separ
phase
specif
arrang
desir
orient
util
method
creat
uniform
microcapsul
control
shell
thick
provid
mechan
drive
forc
aid
thermodynam
driven
process
addit
present
method
limit
use
concentr
polym
immisc
specif
condit
slow
extract
solvent
rather
allow
exact
control
polym
concentr
flow
rate
thu
control
mass
ratio
two
polym
nascent
droplet
result
precis
control
microcapsul
diamet
shell
thick
flexibl
also
util
creat
condit
nascent
droplet
facilit
spread
pcph
plg
core
subsequ
precipit
polym
kinet
trap
microcapsul
arrang
otherwis
would
difficult
achiev
summari
modifi
ppf
technolog
singlestep
method
produc
uniform
polymer
microcapsul
control
size
shell
thick
monodispers
precis
defin
particl
size
distribut
achiev
maintain
desir
polymer
shell
thick
exact
control
volumetr
flowrat
core
shell
materi
also
allow
format
particl
popul
exhibit
discret
increment
increas
shell
thick
addit
advanc
control
particl
architectur
method
develop
modul
local
materi
compound
interest
specif
polym
oil
aqueou
core
encapsul
within
uniform
polymer
shell
potenti
enabl
advanc
area
drug
deliveri
photon
cell
encapsul
catalysi
name
monodispers
microcapsul
advantag
reproduc
control
transport
phenomena
consist
physic
deriv
properti
may
provid
valuabl
assist
varieti
research
area
process
known
electrohydrodynam
ehd
electrostat
ess
spray
use
fabric
microand
nanospher
polymer
materi
method
charg
inject
control
rate
ie
control
current
polym
solut
contain
nozzl
surfac
solut
meniscu
nozzl
open
becom
highli
charg
charg
meniscu
surfac
thu
electr
tension
forc
push
meniscu
surfac
away
nozzl
oppos
surfac
tension
forc
tri
minim
meniscu
surfac
area
figur
electr
forc
increas
increas
charg
inject
final
overcom
surfac
tension
forc
eject
charg
solut
meniscu
surfac
net
result
increas
charg
inject
gradual
reduct
size
drop
leav
nozzl
socal
drip
mode
develop
singlejet
mode
increas
charg
inject
jet
mode
invok
electr
tension
forc
charg
meniscu
surfac
charg
solut
liter
pull
away
nozzl
orific
thin
jet
turn
natur
break
charg
droplet
due
jet
instabl
charg
inject
increas
singlejet
mode
develop
multijet
mode
one
jet
eman
charg
meniscu
surfac
nozzl
open
sinc
electr
tension
forc
act
meniscu
surfac
function
surfac
charg
densiti
effect
increas
flow
rate
similar
decreas
charg
inject
figur
show
sequenc
figur
ffess
sequenc
increas
voltag
ad
jet
format
use
wv
solut
plg
dlg
methylen
chlorid
flow
mlh
voltag
increas
kv
eh
multijet
mode
sprya
wv
plg
dlg
acetonitril
flow
mlh
voltag
increas
kv
charg
inject
achiev
use
sharpen
tungsten
needl
encas
glass
capillari
orific
posit
cm
ground
plate
event
take
place
charg
voltag
ie
charg
inject
increas
plg
solut
phenomena
describ
gener
known
ehd
spray
typic
flow
rate
use
necessarili
small
fiber
produc
final
product
possibl
polymer
solut
materi
molten
state
process
often
refer
electrospin
altern
electrohydrodynam
method
call
flowlimit
fieldinject
electrostat
spray
ffess
kim
et
al
kim
et
al
berkland
et
al
develop
ffess
use
alon
tandem
acoust
method
describ
preced
section
ffess
charg
inject
achiev
use
nanosharpen
tungsten
needl
connect
high
voltag
process
call
field
inject
field
emiss
ioniz
depend
whether
polar
figur
uniform
particl
produc
spray
wv
dlg
plg
aceton
flow
mlh
appli
kv
needl
posit
cm
ground
plate
scale
bar
b
uniform
particl
produc
spray
wv
dlg
plg
methylen
chlorid
flow
mlh
use
ffess
kv
apppli
sharpen
tungsten
needl
encas
glass
capillari
orific
posit
cm
ground
plate
scale
bar
c
uniform
particl
produc
condit
b
except
solvent
acetonitril
appli
voltag
kv
scale
bar
needl
neg
posit
thu
ffess
process
allow
one
produc
spray
finer
precis
control
produc
convent
ehd
techniqu
employ
conduct
hypoderm
needl
spray
nozzl
figur
main
reason
sharp
chargeinject
electrod
use
ffess
render
control
stabil
higher
charg
inject
kim
kim
applic
involv
advanc
drug
deliveri
effect
key
paramet
control
ffess
process
appli
voltag
polym
solut
flowrat
solvent
properti
surfac
tension
viscos
vapor
pressur
qualit
evalu
exampl
use
ffess
system
wide
varieti
uniform
microand
nanoparticl
plg
creat
figur
discret
vari
product
paramet
subtl
chang
deposit
polym
morpholog
realiz
potenti
result
enhanc
perform
medic
biolog
devic
ffess
technolog
thu
provid
simpl
robust
techniqu
fabric
devic
precis
defin
nanostructur
broad
rang
biocompat
polymer
materi
present
section
brief
review
controlledreleas
literatur
result
sever
control
releas
studi
carri
ppfproduc
microspher
data
clearli
show
releas
model
smallmolecul
drug
vari
typic
diffusioncontrol
profil
slower
sigmoid
profil
microspher
diamet
increas
rang
data
also
show
drug
releas
mixtur
uniform
microspher
correspond
weight
averag
releas
individu
uniform
microspher
result
possibl
choos
appropri
mixtur
gener
desir
releas
rate
profil
particular
constant
ie
zeroord
releas
therefor
conclud
microspher
mixtur
welldefin
size
distribut
may
provid
gener
methodolog
control
drug
releas
rate
longterm
zeroord
releas
smallmolecul
therapeut
biodegrad
microspher
difficult
achiev
releas
small
compound
often
rapid
diffus
control
often
releas
small
molecul
encapsul
polymer
particl
typic
domin
larg
initi
rate
releas
burst
first
h
offer
littl
advantag
convent
oral
dosag
form
examin
effect
microspher
size
size
uniform
drug
releas
kinet
measur
releas
profil
two
model
drug
rhodamin
piroxicam
plg
sphere
rhodamin
releas
profil
shown
figur
expect
microspher
exhibit
faster
initi
releas
microspher
like
due
increas
surfacetovolum
ratio
smaller
particl
drug
load
increas
initi
rate
drug
releas
increas
interest
concaveupward
ie
sigmoid
profil
observ
particl
lesser
extent
particl
wherein
drug
releas
initi
slow
progress
rapid
releas
phase
level
piroxicam
releas
profil
show
similar
trend
figur
sampl
microspher
studi
microspher
span
broader
size
rang
rhodamineload
particl
result
pronounc
differ
drug
releas
profil
smallest
microspher
diamet
exhibit
rapid
initi
rate
releas
encapsul
piroxicam
releas
within
first
hour
initi
releas
rate
decreas
increas
microspher
diamet
drug
load
examin
initi
releas
rate
decreas
increas
drug
load
interestingli
particl
exhibit
sigmoid
releas
profil
similar
rhodamin
releas
microspher
model
releas
elucid
mechan
control
vari
shape
releas
profil
model
assum
simpl
diffusioncontrol
releas
incorpor
initi
nonuniform
drug
distribut
microspher
timedepend
diffus
show
effect
drug
diffus
increas
decreas
polym
molecular
weight
caus
degrad
way
abl
accur
predict
shape
kinet
smallmolecul
releas
profil
model
facilit
design
microspher
system
provid
desir
releas
rate
constant
releas
highli
desir
mani
drug
deliveri
applic
transit
concav
downward
sigmoid
releas
profil
sphere
size
increas
appear
nearli
linear
releas
may
achiev
certain
size
exampl
microspher
size
may
exist
would
provid
zeroord
piroxicam
releas
durat
cf
figur
other
report
linear
nearlinear
releas
profil
achiev
microspher
similar
size
diamet
exampl
woo
et
al
formul
leuprolid
deliveri
system
use
pla
microspher
averag
diamet
achiev
nearlinear
peptid
releas
day
follow
period
diffusioncontrol
releas
earli
phase
releas
may
result
portion
microspher
formul
would
expect
releas
drug
rapidli
bezem
et
al
use
poli
ethylen
glycol
poli
butylen
terephthal
pegpbt
block
copolym
test
effect
microspher
size
drug
releas
also
discov
decreas
averag
microspher
size
caus
releas
kinet
chang
gradual
zeroord
releas
releas
control
fickian
diffus
research
suggest
drug
deliveri
rate
may
control
mix
microspher
vari
size
characterist
exampl
ravivarapu
et
al
mix
microspher
compris
plg
encapsul
leuprolid
acet
lowmolecularweight
polym
result
porou
quickli
releas
microspher
highmolecularweight
formul
result
dens
microspher
produc
sigmoid
releas
profil
mix
microspher
compris
two
polym
releas
rate
could
tailor
result
profil
linear
combin
result
individu
microspher
bezem
et
al
produc
linear
lysozym
releas
day
pegpbt
microspher
bimod
size
distribut
domin
particl
essenc
combin
two
size
final
narayani
et
al
combin
gelatin
microspher
variou
size
rang
produc
zeroord
releas
methotrex
gener
howev
zeroord
releas
difficult
achiev
simpl
microspher
system
littl
gener
uniqu
system
design
empir
drug
base
differ
shape
uniform
ppf
microspher
releas
profil
given
reproduc
ppf
methodolog
uniform
microspher
fabric
reason
may
possibl
modul
releas
kinet
desir
fashion
mix
appropri
proport
two
uniform
microspher
prepar
figur
investig
gener
hypothesi
mix
uniform
microspher
differ
size
gener
zeroord
releas
rhodamin
clinic
relev
nsaid
piroxicam
exampl
multipl
linear
combin
piroxicamcontain
microspher
variou
drug
load
examin
comput
identifi
combin
result
linear
drug
releas
two
possibl
formul
found
first
formul
combin
microspher
ratio
wt
wt
formul
result
slightli
concav
downward
releas
profil
ratio
linear
drug
releas
profil
wt
wt
mixtur
figur
summari
releas
kinet
uniform
sphere
predict
reproduc
abil
fabric
uniform
microspher
enhanc
techniqu
found
upon
mix
uniform
microspher
prepar
result
releas
profil
massweight
averag
releas
profil
individu
microspher
demonstr
microspher
releas
payload
independ
interact
particl
experi
shape
rhodamin
piroxicam
releas
profil
possibl
choos
appropri
microspher
mixtur
provid
zeroord
releas
kinet
figur
howev
may
alway
possibl
gener
desir
releas
profil
mixtur
two
microspher
size
depend
desir
profil
shape
individu
releas
curv
one
may
need
mix
multipl
microspher
sampl
fabric
complex
microspher
size
distribut
ppf
method
provid
uniqu
abil
gener
predefin
microspher
size
technolog
may
lead
enhanc
control
releas
rate
doublewal
microspher
repres
increasingli
import
class
drug
deliveri
devic
provid
enhanc
control
drug
deliveri
schedul
clearli
overal
particl
size
shell
thick
import
paramet
modul
drug
releas
rate
one
studi
ppf
use
fabric
doublewal
microspher
predefin
uniform
diamet
exhibit
plg
core
poli
llactid
pl
shell
control
thick
approxim
vitro
releas
piroxicam
uniform
microspher
pure
plg
pl
compar
releas
doublewal
microspher
exhibit
differ
pl
shell
thick
figur
benefit
util
pl
shell
around
plg
core
threefold
first
presenc
pl
shell
minim
initi
drug
burst
often
associ
microparticlebas
drug
deliveri
system
secondli
figur
vitro
releas
piroxicam
ppf
particl
drugfre
pll
shell
plg
core
contain
piroxicam
legend
show
weight
ratio
pll
plg
specif
control
mass
ratio
pl
plg
thu
result
pl
shell
thick
releas
piroxicam
progress
modul
biphas
shell
zeroord
thickest
shell
figur
lastli
durat
piroxicam
releas
extend
one
month
three
month
util
molecular
weight
plg
abil
specif
control
doublewal
microspher
shell
thick
may
provid
novel
precis
approach
modul
drug
releas
profil
macromolecular
therapeut
peptid
protein
dna
advanc
rapidli
toward
clinic
typic
low
oral
bioavail
invas
deliveri
method
frequent
repeat
inject
requir
parenter
depot
includ
biodegrad
polym
microspher
offer
possibl
reduc
dose
frequenc
limit
inabl
adequ
control
deliveri
rate
releas
macromolecul
typic
exhibit
initi
burst
drug
much
drug
load
follow
lag
phase
exhibit
slow
releas
final
period
steadi
releas
initi
burst
protein
therapeut
attribut
tendenc
partit
microspher
surfac
encapsul
process
multipl
approach
attempt
allevi
burst
ad
excipi
polym
phase
util
novel
polym
encapsul
particul
form
drug
exchang
nonsolv
aqueou
phase
use
fabric
process
nonpolar
oil
alcohol
reduc
affin
encapsul
drug
bulk
phase
burst
usual
follow
lag
period
diffus
limit
littl
releas
macromolecul
occur
durat
flat
phase
determin
polym
degrad
kinet
particl
size
microspher
poros
addit
drug
size
charg
potenti
interact
drug
polym
influenc
lag
phase
final
lag
phase
follow
period
steadi
releas
typic
control
polym
degrad
rate
control
releas
investig
releas
mechan
model
macromolecul
encapsul
uniform
poli
llactidecoglycolid
plg
microspher
use
ppf
combin
doubleemuls
method
precis
particl
fabric
ppf
technolog
describ
section
allow
product
monodispers
microspher
fluoresceindextran
fdex
sulforhodaminelabel
bovin
serum
albumin
rbsa
encapsul
plg
microspher
three
differ
size
diamet
fdex
rbsa
respect
figur
notabl
initi
burst
drug
often
observ
releas
hydrophil
macromolecul
observ
hour
fdexload
microspher
releas
total
encapsul
drug
three
microspher
size
rbsaload
microspher
releas
depend
microspher
diamet
uniform
microspher
durat
slow
releas
lag
phase
vari
microspher
diamet
addit
slow
releas
phase
formul
appear
diffusioncontrol
process
rate
decreas
increas
sphere
diamet
plot
amount
releas
versu
squar
root
time
show
diffusioncontrol
phase
last
day
depend
microspher
size
releas
uniform
microspher
show
two
phase
lag
rapid
releas
fdex
releas
profil
distinct
three
differ
size
diffusioncontrol
lag
period
follow
sharp
increas
releas
rate
figur
time
releas
rate
increas
strongli
depend
upon
invers
proport
microspher
size
lag
period
releas
rate
molecul
increas
dramat
thu
uniform
microspher
repres
new
deliveri
system
therapeut
protein
dna
provid
unpreced
control
deliveri
rate
use
simpl
inject
depot
formul
develop
ppf
technolog
allow
product
uniform
microspher
doublewal
microspher
capabl
effici
encapsul
model
drug
primari
import
abil
monodispers
microspher
formul
elimin
initi
drug
burst
modul
onset
steadi
drug
releas
modifi
ppf
technolog
also
establish
singlestep
method
produc
uniform
polymer
microcapsul
control
size
shell
thick
monodispers
precis
defin
particl
size
distribut
achiev
maintain
desir
polymer
shell
thick
exact
control
volumetr
flowrat
core
shell
materi
also
allow
format
particl
popul
exhibit
discret
increment
increas
shell
thick
control
releas
system
especi
compris
biodegrad
polym
microparticl
heavili
studi
even
reach
clinic
sever
case
howev
notabl
limit
remain
especi
control
deliveri
rate
monodispers
ppf
microspher
coreshel
microparticl
offer
advantag
reproduc
control
consist
may
provid
valuabl
assist
design
advanc
drug
deliveri
system
ffess
techniqu
capabl
produc
nanometerscal
solid
particl
small
nm
even
smaller
may
applic
fabric
nanocapsul
howev
achiev
precis
control
particl
size
reproduc
fabric
nanocapsul
technolog
need
refin
develop
